Theseus Pharmaceuticals, Inc. (THRX): Price and Financial Metrics

Theseus Pharmaceuticals, Inc. (THRX): $4.06

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add THRX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#116 of 356

in industry

THRX Price/Volume Stats

Current price $4.06 52-week high $12.37
Prev. close $4.06 52-week low $2.05
Day low $4.06 Volume 3,123,100
Day high $4.07 Avg. volume 592,167
50-day MA $3.96 Dividend yield N/A
200-day MA $4.97 Market Cap 179.57M

THRX Stock Price Chart Interactive Chart >


Theseus Pharmaceuticals, Inc. (THRX) Company Bio


Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-variant inhibitor for activating and resistance mutations of the KIT kinase or a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors (GIST), a type of cancer characterized by oncogenic activation of KIT. The company also develops fourth-generation EGFR inhibitor that is active against C797S, an EGFR mutation that causes resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer. Its development programs address drug resistance mutations in key driver oncogenes, which are mutated genes that cause cancer. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.


THRX Latest News Stream


Event/Time News Detail
Loading, please wait...

THRX Latest Social Stream


Loading social stream, please wait...

View Full THRX Social Stream

THRX Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year 17.68%
3-year -77.00%
5-year N/A
YTD 0.25%
2023 -18.67%
2022 -60.73%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!